John Dick

Researcher
  • Ontario Institute for Cancer Research
  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Multiple Cancers

    Determinants of stemness that underlie high risk or relapse disease

    There’s an analogy that Dr. John Dick likes to use to describe cancer. For him, cancer is like a weed, with the tumour being the leafy part that sits above ground. The roots, on the other hand, ...

    Read More
  • Completed
    Multiple Cancers

    Development of stemness-based prognostic biomarkers and therapeutic targets

    There is an analogy senior scientist Dr. John Dick uses when explaining his TFRI-funded cancer stem cell (CSC) research. He compares cancer to a weed that has a separate root to the stem, branches and...

    Read More

Related News & Events

  • Research Highlight|October 21, 2021

    Study reveals a new target that suggests leukemia in children with Down syndrome could be prevented

    TFRI-funded researchers in Toronto have uncovered new information on the intricate relationship between the extra copy of chromosome 21 and leukemia, ...

  • Research Highlight|December 10, 2020

    Two New Frontiers Program Project Grant teams receive $10.9 million for research excellence, expansion to new key areas

    Two outstanding teams in Ontario will receive $10.9 million over the next six years to advance research into key areas of cancer development after bei...

  • Research Highlight|November 30, 2020

    Mapping out the mystery of blood stem cells

    Using state-of-the art sequencing technology, Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughou...

  • Research Highlight|May 27, 2020

    Team isolates rare clones destined to cause relapse within diagnosis samples of acute lymphoblastic leukemia

    Diagnosis relapse initiating (dRI) clones have unique characteristics that favor relapse and can be found in diagnosis samples from patients, meaning ...

  • Research Highlight|October 04, 2019

    Toronto-based team identifies potential target to supress leukemia stem cells

    Targeting a gene called INKA1 may supress leukemia stem cells (LSCs), stopping the disease in its tracks or preventing relapse in patients who have al...

  • Research Highlight|July 11, 2018

    Leukemia researchers discover genetic screening tool to predict healthy people at risk of developing aggressive form of leukemia

    An international team of leukemia scientists that includes TFRI-funded researchers has discovered how to predict healthy individuals at risk of develo...

  • Research Highlight|May 15, 2018

    Blocking donor T cell–mediated TNF? signaling can enhance positive effects of stem cell transplantation

    A collaboration between Swiss and Canadian research institutes has shown an effective way to enhance human hematopoietic stem and progenitor cell engr...

  • TFRI News|February 08, 2018

    2017 Marathon of Hope Lecture Series

    As part of its 10th anniversary celebration, TFRI presented a session titled The Marathon of Hope Lecture Series at the Canadian Cancer Research Confe...

  • TFRI News|September 06, 2017

    Four premier TFRI investigators will present Marathon of Hope talks at CCRC

    TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featur...

  • All News & Events